Protecting the Future: Essential Neuroprotective Strategies for Preterm Infants
"Discover how early interventions and specialized care can significantly improve neurodevelopmental outcomes in preterm infants, reducing lifelong disabilities."
The survival rates of extremely preterm infants have significantly increased over the past three decades. Despite this progress, these infants still face a substantial risk of lifelong neurodisability. This condition arises from a complex interplay of pathological processes, developmental trajectories, genetic predispositions, and environmental factors, making prevention a multifaceted challenge.
Unlike many medical conditions where a single intervention can suffice, preventing brain injury in preterm infants requires a comprehensive approach. The intricate nature of the problem demands a strategy that addresses various contributing factors, reflecting the complexity of brain development itself.
Fortunately, medical science has identified several interventions—both before and after birth—that show promise in improving neurodevelopmental outcomes. These strategies range from administering steroids and magnesium sulfate before birth to ensuring proper umbilical cord management and nutritional support postnatally. By integrating these practices into routine care, healthcare providers can significantly enhance the prospects for these vulnerable newborns.
Growing Survival, Ongoing Risk
The number of preterm infants has increased over the last several decades, while advances in perinatal care have improved survival. As more preterm infants survive, research has increasingly examined their neurodevelopmental outcomes. Preterm birth remains a major cause of perinatal morbidity and mortality, with around half of all perinatal mortality occurring in preterm babies weighing less than 1500 g. Brain injury is more common in preterm infants than in term infants and is associated with a greater risk of adverse outcomes.
Multifactorial NICU Care
Current neuroprotective care addresses the multifactorial causes of preterm brain injury through antenatal care, seizure management, and non-pharmacological NICU care. One review describes these approaches as strategies currently in use, while a clinical pathway emphasizes the increased risk of developmental delays, behavioral issues, and mental health difficulties among infants born preterm. Implementation of a neuroprotection care bundle targeting predefined risk factors has been reported as feasible and effective in reducing acute brain injury in extremely preterm infants. However, the continuing risk of adverse outcomes shows that accepted care methods reduce risk rather than eliminate it.
Recognizing Developmental Vulnerability
Neuroprotective thinking developed from recognition that preterm infants encounter extra-uterine stresses during a critical period of brain development and maturation. During the late second and third trimesters, white- and grey-matter volumes increase dramatically, while the cortex folds into complex gyri as neural and glial cells proliferate, differentiate, and migrate. Neurocritical care subsequently emerged as a multidisciplinary approach intended to reduce neurologic injury among critically ill patients. Premature infants were identified as especially vulnerable to brain injury and adverse neurodevelopmental outcomes.
Key Antenatal Interventions to Boost Brain Health
The period before birth is critical for brain development, and certain interventions during this time can significantly reduce the risk of neurological issues in preterm infants. These strategies aim to stabilize the mother's condition and create an optimal environment for the developing fetus.
- Importance of Specialized Care: The EPICure 2 study highlights that mortality rates for extremely preterm infants are reduced when born in centers with higher levels of intensive care. Early transfers for women in preterm labor are crucial for ensuring optimal obstetric and neonatal care.
- Antenatal Steroids: A single course of betamethasone or dexamethasone is recommended for women presenting in preterm labor before 35 weeks gestation. Antenatal steroids have been shown to reduce the rates of IVH, severe IVH, and white matter damage.
- Magnesium Sulfate: Administering magnesium sulfate (MgSO4) to women at risk of preterm birth (<37 weeks' gestation) can significantly reduce the rates of moderate and severe cerebral palsy in infants.
Current Evidence Base
A 2019 review by Sammut and Austin, titled "Neuroprotection of the preterm infant," examined neuroprotection in the context of preterm birth. A separate review reports that neonates with very low birth weight below 1500 g, extremely low birth weight below 1000 g, and those born very preterm or extremely preterm are at high risk for neurodevelopmental disabilities. Together, these sources show that current research combines broad neuroprotection reviews with focused attention to the populations at greatest developmental risk.
Experimental Versus Clinical Evidence
Evidence for neuroprotective techniques varies substantially by model and clinical application. In adult human dorsal root ganglion neurons, hypothermia alone produced a fourfold increase in neuroprotection, alkalinization alone produced an eightfold increase, and the combination produced a 26-fold increase. By contrast, a review focused on preterm infants identifies perinatal asphyxia, infection or inflammation, chronic hypoxia, mechanical ventilation, and corticosteroid exposure as influences on brain injury, while noting that treatment options are currently very limited. Findings from adult neuronal experiments therefore should not be treated as established therapies for preterm infants.
Charting the Course for Future Research
As survival rates for preterm infants continue to rise, so does the urgency to discover and refine neuroprotective strategies. Current research is exploring promising new avenues, including the use of melatonin, erythropoietin, and stem cell therapy. While these treatments are still in early stages, they hold potential for further reducing neurological impairments. Raising awareness and implementing current best practices remain essential to improve outcomes for this vulnerable population.
Broadening Neuroprotection
Future strategies described in the literature span prevention of preterm birth and pre-, peri-, and postnatal approaches to protect the developing brain. Research directions include therapies during the antepartum and postnatal periods, as well as seizure management and non-pharmacological NICU care. The 2023 review also describes neuroprotective strategies as addressing the multifactorial pathogenesis of preterm brain injury. These directions aim to improve outcomes while recognizing that neonatal neuroprotection remains focused on safeguarding the developing brain from injury.